Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03349450
Title DPX-Survivac and Checkpoint Inhibitor in DLBCL (SPiReL)
Acronym SPiReL
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Sunnybrook Health Sciences Centre
Indications
Therapies
Age Groups: adult | senior
Covered Countries CAN

Facility Status City State Zip Country Details
Tom Baker Cancer Centre - Alberta Health Services Calgary Alberta Canada Details
Nova Scotia Health Authority: Queen Elizabeth II Health Sciences Centre Halifax Nova Scotia B3H 2Y9 Canada Details
London Health Sciences Centre London Ontario N6A 5W9 Canada Details
Ottawa Hospital Research Institute Ottawa Ontario Canada Details
Sunnybrook Health Sciences Centre, Odette Cancer Centre Toronto Ontario M4N 3M5 Canada Details
McGill University Health Centre Montréal Quebec Canada Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field